Zhenfang Du
Southeast University(BD)Southeast University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cancer therapeutics and mechanisms, Epigenetics and DNA Methylation, RNA modifications and cancer
Most-Cited Works
- → Mechanisms of receptor tyrosine kinase activation in cancer(2018)1,039 cited
- → Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers(2016)126 cited
- → On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation(2019)107 cited
- → Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting(2021)68 cited
- → Characterization of the Nasopharyngeal Carcinoma Methylome Identifies Aberrant Disruption of Key Signaling Pathways and Methylated Tumor Suppressor Genes(2014)65 cited
- → Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis(2019)51 cited
- → RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family(2011)45 cited
- → Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas(2017)43 cited
- → Genetic diagnosis of autosomal dominant polycystic kidney disease by targeted capture and next-generation sequencing: Utility and limitations(2012)42 cited
- → Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer(2024)41 cited